Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma.
Burack WR, Li H, Adlowitz D, Spence JM, Rimsza LM, Shadman M, Spier CM, Kaminski MS, Leonard JP, Leblanc ML, Smith SM, Friedberg JW.
Burack WR, et al. Among authors: spence jm.
Blood Adv. 2023 Sep 12;7(17):5082-5090. doi: 10.1182/bloodadvances.2022009467.
Blood Adv. 2023.
PMID: 37379264
Free PMC article.
Clinical Trial.